Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation.

Mürner CM, Stenner-Liewen F, Seifert B, Mueller NJ, Schmidt A, Renner C, Schanz U, Knuth A, Manz MG, Scharl M, Gerber B, Samaras P.

Leuk Lymphoma. 2019 Mar;60(3):685-695. doi: 10.1080/10428194.2018.1496332. Epub 2018 Aug 21.

PMID:
30126310
2.

Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study.

Samaras P, Rütti MF, Seifert B, Bachmann H, Schanz U, Eisenring M, Renner C, Susanne Müller AM, Schmidt A, Mischo A, Fuchs I, Bargetzi M, Manz MG, Stupp R, Petrausch U, Stenner-Liewen F.

Biol Blood Marrow Transplant. 2018 Apr;24(4):694-699. doi: 10.1016/j.bbmt.2017.12.775. Epub 2017 Dec 12.

3.

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade.

Läubli H, Hench J, Stanczak M, Heijnen I, Papachristofilou A, Frank S, Zippelius A, Stenner-Liewen F.

J Immunother Cancer. 2017 Jun 20;5:46. doi: 10.1186/s40425-017-0249-y. eCollection 2017.

4.

Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis.

Juskevicius D, Lorber T, Gsponer J, Perrina V, Ruiz C, Stenner-Liewen F, Dirnhofer S, Tzankov A.

Leukemia. 2016 Dec;30(12):2385-2395. doi: 10.1038/leu.2016.135. Epub 2016 May 20.

PMID:
27198204
5.

Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients.

Maul JT, Stenner-Liewen F, Seifert B, Pfrommer S, Petrausch U, Kiessling MK, Schanz U, Nair G, Mischo A, Taverna C, Schmidt A, Bargetzi M, Stupp R, Renner C, Samaras P.

J Clin Apher. 2017 Feb;32(1):21-26. doi: 10.1002/jca.21459. Epub 2016 Mar 22.

PMID:
27001243
6.

Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial.

Meisel A, von Felten S, Vogt DR, Liewen H, de Wit R, de Bono J, Sartor O, Stenner-Liewen F.

Eur J Cancer. 2016 Mar;56:93-100. doi: 10.1016/j.ejca.2015.12.009. Epub 2016 Jan 30.

PMID:
26829012
7.

Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder.

Läubli H, Tzankov A, Juskevicius D, Degen L, Rochlitz C, Stenner-Liewen F.

Leuk Lymphoma. 2016;57(4):945-8. doi: 10.3109/10428194.2015.1083563. Epub 2015 Oct 8. No abstract available.

PMID:
26295731
8.

Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity.

Uda NR, Seibert V, Stenner-Liewen F, Müller P, Herzig P, Gondi G, Zeidler R, van Dijk M, Zippelius A, Renner C.

J Enzyme Inhib Med Chem. 2015 Dec;30(6):955-60. doi: 10.3109/14756366.2014.1001754. Epub 2015 Sep 4.

PMID:
25775095
9.

Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.

Samaras P, Pfrommer S, Seifert B, Petrausch U, Mischo A, Schmidt A, Schanz U, Nair G, Bargetzi M, Taverna C, Stupp R, Stenner-Liewen F, Renner C.

Biol Blood Marrow Transplant. 2015 Jan;21(1):74-80. doi: 10.1016/j.bbmt.2014.09.020. Epub 2014 Sep 30.

10.

Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled Trial.

Stenner-Liewen F, Liewen H, Cathomas R, Renner C, Petrausch U, Sulser T, Spanaus K, Seifert HH, Strebel RT, Knuth A, Samaras P, Müntener M.

J Cancer. 2013 Aug 29;4(7):597-605. doi: 10.7150/jca.7123. eCollection 2013.

11.

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma.

Stenner-Liewen F, Grünwald V, Greil R, Porta C.

Expert Rev Anticancer Ther. 2013 Sep;13(9):1021-33. doi: 10.1586/14737140.2013.833684. Epub 2013 Sep 12. Review.

PMID:
24024788
12.

Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation.

Samaras P, Zardavas D, Petrausch U, Buset EM, Haile SR, Honegger H, Siciliano RD, Schanz U, Mischo A, Schäfer NG, Taverna C, Knuth A, Stahel R, Renner C, Stenner-Liewen F.

Swiss Med Wkly. 2013 May 7;143:w13791. doi: 10.4414/smw.2013.13791. eCollection 2013. No abstract available.

13.

Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience.

Samaras P, Blickenstorfer M, Haile SR, Siciliano RD, Petrausch U, Mischo A, Zweifel M, Honegger H, Schanz U, Stussi G, Taverna C, Bauer S, Knuth A, Stenner-Liewen F, Renner C.

Swiss Med Wkly. 2011 May 31;141:w13203. doi: 10.4414/smw.2011.13203. eCollection 2011.

14.

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis.

Mischo A, Bubel N, Cebon JS, Samaras P, Petrausch U, Stenner-Liewen F, Schaefer NG, Kubuschok B, Renner C, Wadle A.

Int J Oncol. 2011 Jul;39(1):287-94. doi: 10.3892/ijo.2011.1032. Epub 2011 May 6.

PMID:
21573493
15.

Temsirolimus is highly effective as third-line treatment in chromophobe renal cell cancer.

Zardavas D, Meisel A, Samaras P, Knuth A, Renner C, Pestalozzi BC, Stenner-Liewen F.

Case Rep Oncol. 2011 Jan 15;4(1):16-8. doi: 10.1159/000323804.

16.

Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.

Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.

Ann Surg Oncol. 2011 Jul;18(7):1924-31. doi: 10.1245/s10434-010-1505-2. Epub 2011 Jan 5.

PMID:
21207165
17.

Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial.

Knols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, Hitz F, Taverna C, Aaronson NK.

Bone Marrow Transplant. 2011 Sep;46(9):1245-55. doi: 10.1038/bmt.2010.288. Epub 2010 Dec 6.

18.

Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.

Samaras P, Buset EM, Siciliano RD, Haile SR, Petrausch U, Mischo A, Honegger H, Pestalozzi BC, Schanz U, Stussi G, Stahel RA, Knuth A, Renner C, Stenner-Liewen F.

Oncology. 2010;79(1-2):93-7. doi: 10.1159/000320604. Epub 2010 Nov 15.

19.

Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim.

Samaras P, Blickenstorfer M, Siciliano RD, Haile SR, Buset EM, Petrausch U, Mischo A, Honegger H, Schanz U, Stussi G, Stahel RA, Knuth A, Stenner-Liewen F, Renner C.

Ann Hematol. 2011 Jan;90(1):89-94. doi: 10.1007/s00277-010-1036-8. Epub 2010 Aug 13.

PMID:
20706722
20.

Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP.

Samaras P, Heider H, Haile SR, Petrausch U, Schaefer NG, Siciliano RD, Meisel A, Mischo A, Zweifel M, Knuth A, Stenner-Liewen F, Renner C.

Ann Hematol. 2010 Aug;89(8):783-7. doi: 10.1007/s00277-010-0926-0. Epub 2010 Mar 5.

PMID:
20204361
21.

Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma.

Zweifel M, Stenner-Liewen F, Weber A, Samaras P, Zaugg K, Knuth A, Soyka JD.

Clin Nucl Med. 2010 Feb;35(2):103-4. doi: 10.1097/RLU.0b013e3181c7be63. No abstract available.

PMID:
20090458
22.

Rational development of high-affinity T-cell receptor-like antibodies.

Stewart-Jones G, Wadle A, Hombach A, Shenderov E, Held G, Fischer E, Kleber S, Nuber N, Stenner-Liewen F, Bauer S, McMichael A, Knuth A, Abken H, Hombach AA, Cerundolo V, Jones EY, Renner C.

Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5784-8. doi: 10.1073/pnas.0901425106. Epub 2009 Mar 23. Erratum in: Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10872. Nuber, Natko [added].

23.

Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.

Samaras P, Dold S, Braun J, Kestenholz P, Breitenstein S, Imhof A, Renner C, Stenner-Liewen F, Pestalozzi BC.

Oncology. 2008;74(3-4):237-44. doi: 10.1159/000151393. Epub 2008 Aug 21.

24.

Treatment of POEMS syndrome with bevacizumab.

Samaras P, Bauer S, Stenner-Liewen F, Steiner R, Zweifel M, Renner C, Knuth A.

Haematologica. 2007 Oct;92(10):1438-9.

25.

Images in cardiovascular medicine. Infarction-like electrocardiographic changes due to a myocardial metastasis from a primary lung cancer.

Samaras P, Stenner-Liewen F, Bauer S, Goerres GW, von Boehmer L, Kotrubczik N, Jenni R, Renner C, Knuth A.

Circulation. 2007 Mar 13;115(10):e320-1. No abstract available.

PMID:
17353451
26.

[Molecular targeted therapy].

Stenner-Liewen F, Zippelius A, Pestalozzi BC, Knuth A.

Chirurg. 2006 Dec;77(12):1118-25. Review. German.

27.

Characterization of Hap/BAG-1 variants as RP1 binding proteins with antiapoptotic activity.

Wadle A, Mischo A, Henrich PP, Stenner-Liewen F, Scherer C, Imig J, Petersen G, Pfreundschuh M, Renner C.

Int J Cancer. 2005 Dec 20;117(6):896-904. Erratum in: Int J Cancer. 2007 Sep 15;121(6):1399. Stenner-Lieven, Frank [corrected to Stenner-Liewen, Frank].

28.

Characterization of the human GARP (Golgi associated retrograde protein) complex.

Liewen H, Meinhold-Heerlein I, Oliveira V, Schwarzenbacher R, Luo G, Wadle A, Jung M, Pfreundschuh M, Stenner-Liewen F.

Exp Cell Res. 2005 May 15;306(1):24-34.

PMID:
15878329
29.

Crystal structure of PqqC from Klebsiella pneumoniae at 2.1 A resolution.

Schwarzenbacher R, Stenner-Liewen F, Liewen H, Reed JC, Liddington RC.

Proteins. 2004 Aug 1;56(2):401-3. No abstract available.

PMID:
15211525
30.

Structure of the Chlamydia protein CADD reveals a redox enzyme that modulates host cell apoptosis.

Schwarzenbacher R, Stenner-Liewen F, Liewen H, Robinson H, Yuan H, Bossy-Wetzel E, Reed JC, Liddington RC.

J Biol Chem. 2004 Jul 9;279(28):29320-4. Epub 2004 Apr 15.

31.

BAG1 over-expression in brain protects against stroke.

Kermer P, Digicaylioglu MH, Kaul M, Zapata JM, Krajewska M, Stenner-Liewen F, Takayama S, Krajewski S, Lipton SA, Reed JC.

Brain Pathol. 2003 Oct;13(4):495-506.

PMID:
14655755
32.

CADD, a Chlamydia protein that interacts with death receptors.

Stenner-Liewen F, Liewen H, Zapata JM, Pawlowski K, Godzik A, Reed JC.

J Biol Chem. 2002 Mar 22;277(12):9633-6. Epub 2002 Jan 22.

33.

Identification and characterization of DEDD2, a death effector domain-containing protein.

Roth W, Stenner-Liewen F, Pawlowski K, Godzik A, Reed JC.

J Biol Chem. 2002 Mar 1;277(9):7501-8. Epub 2001 Dec 11.

34.

Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer.

Meinhold-Heerlein I, Stenner-Liewen F, Liewen H, Kitada S, Krajewska M, Krajewski S, Zapata JM, Monks A, Scudiero DA, Bauknecht T, Reed JC.

Am J Pathol. 2001 Apr;158(4):1335-44.

35.

Definition of tumor-associated antigens in hepatocellular carcinoma.

Stenner-Liewen F, Luo G, Sahin U, Tureci O, Koslovski M, Kautz I, Liewen H, Pfreundschuh M.

Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):285-90.

Supplemental Content

Loading ...
Support Center